TCIM
BMY icon

TOMS Capital Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

TOMS Capital Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-150,000
Closed -$7.16M – 11
2019
Q1 		$7.16M Buy
+150,000
New +$7.47M 1.63% 12

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TOMS Capital Investment Management's BMY Position: Q2 2019 in Review

TOMS Capital Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 150,000 shares — an estimated $7.16M sold.

TOMS Capital Investment Management first reported a position in BMY in Q1 2019 and held it in 1 quarter. The position peaked at $7.16M in Q1 2019. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

  • TOMS Capital Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
  • TOMS Capital Investment Management sold 150,000 Bristol-Myers Squibb shares in Q2 2019, an estimated $7.16M.
  • TOMS Capital Investment Management first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 1 quarter.
  • TOMS Capital Investment Management's Bristol-Myers Squibb position peaked at $7.16M in Q1 2019.
  • 1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on TOMS Capital Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.